Cardiac hypertrophy is accompanied by reprogramming of gene expression, where the altered expression of ion channels decreases electrical stability and increases the risk of life-threatening arrhythmias. However, the underlying mechanisms are not fully understood. Here, we analysed the role of the depolarizing current I f which has been hypothesized to contribute to arrhythmogenesis in the hypertrophied ventricle.
Introduction
Cardiac hypertrophy develops when the heart is faced with an increased workload or injury. Physiological hypertrophy occurs in response to strong exercise, whereas pathological hypertrophy develops in response to pressure or volume overload or myocardial infarction. The pathological form frequently results in decreased ventricular function and heart failure 1 and is associated with an increased risk of potentially lethal arrhythmias. A major arrhythmogenic mechanism is action potential prolongation, which as an early compensatory response increases intracellular Ca 2+ and contractility, but in the long term produces repolarization abnormalities and electrical instability. 2, 3 The mechanisms underlying action potential prolongation are not fully understood, but reductions in K + currents play an important role. 2, 4 However, an increase in depolarizing currents might also contribute. We examined the pathophysiological role of the depolarizing current I f in cardiac hypertrophy. Four isoforms of hyperpolarizationactivated cyclic nucleotide-gated channels (HCN1-4) generate this current. In the sinoatrial (SA) node, I f plays an important role in setting the heart rate and mediating its modulation, in particular in response to beta-adrenergic stimulation. 5 -9 However, expression of HCN channels is not limited to the cardiac pacemaking and conduction system. I f is present in ventricular myocytes from embryos and newborns, its expression then declines during postnatal development. 10, 11 Several groups reported an upregulation of ventricular I f in cardiac hypertrophy and failure. 12 -16 These studies included rats suffering from cardiac hypertrophy 12, 13 and failing human hearts. 14 -16 Based on these observations, it has been repeatedly suggested that an increase in the depolarizing I f current in working myocardium may contribute to the generation of arrhythmias in cardiac disease. 12 -18 However, any direct evidence for such a proarrhythmic role of the current is lacking. An additional finding suggesting a possible role of I f in heart failure is provided from a recent large clinical trial 19 which showed that the I f -blocker ivabradine significantly reduced cardiovascular death in heart failure patients. It was proposed that this effect was accounted for by the heart rate reducing properties of the drug, i.e. by inhibition of I f in the SA node. However, this hypothesis was strongly questioned and proposed that the mechanism lies beyond heart-rate lowering. 20 It is possible that the beneficial effect is related, at least in part, to the block of HCN channels in ventricular myocytes.
We first characterized I f in a murine model of ventricular hypertrophy and determined the expression profile of HCN channels in the ventricle. We then generated conditional knockout (KO) mice lacking the relevant HCN isoforms in working myocardial cells by using the Cre/loxP system and examined these animals before and after induction of hypertrophy.
Methods
An expanded Materials and Methods section is available in the Supplementary Material.
Experimental animals
Floxed HCN2, floxed HCN4, and MCK-Cre mice have been described previously. 21 -23 The lines were backcrossed to a C57BL/6J background for six generations and were then intercrossed to generate HCN2 
Transverse aortic constriction (TAC)
Pressure overload-induced left ventricular hypertrophy was produced in 6 -8-week-old mice by TAC. Animals were anaesthetized with a pentobarbital-NaCl/EtOH solution (0.05 g/kg i.p.). The adequate depth of anaesthesia was determined by a negative toe-pinch reflex. If the anaesthesia was not sufficient, then a top-up dose of 20% of the initial dose was given. When deep anaesthesia was confirmed, 0.1 mg/kg buprenorphine was given subcutaneously. Animals were intubated with an intubation cannula (stainless steel, 1.0 mm OD, 28 mm length, Harvard Apparatus, Holliston, USA) to guarantee steady ventilation by a rodent minivent (Hugo Sachs Elektronik, March-Hugstetten, Germany). The chest was opened via a sternal cut and the thoracic aorta was identified. A 7-0 silk suture was placed around the transverse aorta (between the carotis communis sinistra and the truncus brachiocephalicus) and tied around a 27-gauge needle, which was subsequently removed. 24 After suturation of thorax and skin, the intubation cannula was removed. The mice were warmed under infrared light source until they recovered from anaesthesia. Immediately after the operation, 0.5 mL of pre-warmed (378C) saline was applied intraperitoneally. For postoperative analgesia, 0.1 mg/kg buprenorphine was given every 8 h for the next 48 h. Control mice for this procedure (i.e. genetic CTR and KO animals) underwent a corresponding sham operation. The successful banding and the progression of cardiac hypertrophy were examined by echocardiographic measurements before and 8 weeks after the TAC procedure using a Vevo 2100 High-Resolution in Vivo Micro-Imaging System and RMV 707B Scanhead (VisualSonics Inc.). All other experiments using TAC mice were performed 10 -12 weeks after banding.
X-gal staining and isolation of ventricular cardiomyocytes
Whole-mount X-gal staining was done as described 22 by using ROSA26 mice crossed with MCK-Cre animals. Ventricular myocytes were isolated by using a Langendorff-perfusing protocol. Cell surface area was determined by using the microscopic image analysis software.
Quantitative reverse transcription qRT-PCR
RNA expression levels were quantified with Taq Man Gene Expression Assays (Applied Biosystems) as described. 25 
Electrophysiological analysis in ventricular cells
I f from ventricular myocytes was recorded at a temperature of 22 + 28C using whole cell patch clamp recording techniques basically as described. 25 Action potentials were recorded in the perforated-patch configuration at a temperature of 37 + 18C. Composition of solutions, calculation of I f , and action potential parameters are given in the Supplementary Material.
ECG recordings
ECG recordings were done by using needle electrodes and implanted telemetry transmitters as described. 26 Radiotelemetric ECG transmitters (DSI, St Paul, USA) were implanted into the peritoneal cavity under general anaesthesia with isoflurane/O 2 (1.2-2.5% isoflurane). The ECG leads were sutured subcutaneous onto the upper right chest muscle and the upper left abdominal wall muscle (Lead II). For postoperative analgesia, 0.1 mg/kg buprenorphine was given subcutaneously. The animals were allowed to recover for at least 3 weeks. For long-term ECG recordings, data were sampled for 20 s every 10 min.
Electrophysiological studies on isolated hearts
Hearts were subjected to the electrophysiological study on a standardized, isolated, retrogradely perfused Langendorff apparatus during constant perfusion. 27, 28 Established protocols to provoke ventricular arrhythmias, namely AV block 27, 29, 30 and programmed ventricular stimulation 26, 31, 32 at baseline and during stimulation with orciprenalin, 26,27,29 -31 were used. Action potential durations (APDs) and spontaneous and induced arrhythmias were examined. Ventricular monophasic action potentials were assessed following published methods.
27,28
Statistical analysis
All experiments and primary analyses were blinded. Data are presented as mean + standard error of the mean. Statistical analyses were carried out using by using ANOVA followed by Student's t-test with the Bonferroni correction and Chi-square test. A P-value of ,0.05 was considered statistically significant.
Results

Induction of cardiac hypertrophy by TAC
We used constriction of the transverse aorta to induce a pressure overload-induced left ventricular hypertrophy. 24 Hearts from control mice after the TAC procedure (TAC CTR , for nomenclature of experimental animals, see Materials and Methods) displayed clear signs of cardiac remodelling processes when compared with sham-operated animals. Heart size was markedly increased and the heart/body weight ratio (HBR) was significantly enhanced from 6.2 + 0.1 (n ¼ 54) to 11.5 + 0.2 mg/g (n ¼ 43, P , 0.001, Figure 1A ). Heart slices showed collagen deposition and an increased ventricular wall thickness particularly of the septum and the left ventricle ( Figure 1B ). Isolated ventricular myocytes had a significantly increased cell size as demonstrated by a surface area augmented by 60% ( Figure 1C , Supplementary material online, Figure S1C ). Echocardiographic examinations corroborate the successful banding and the increase in ventricular mass and size (Supplementary material online, Figure S1A ). In addition, the expression level of the hypertrophic marker gene atrial natriuretic factor (ANF) was significantly increased in the working myocardium of TAC CTR animals as shown by quantitative reverse transcription PCR (qRT -PCR) analyses ( Figure 1D ) and immunofluorescence staining with an ANF-specific antibody (data not shown). The strong induction of ANF in myocytes of the left and right ventricle (14-and 21-fold, respectively) as well as the echocardiographic examinations are consistent with the presence of pathological hypertrophy and pointed to the transition from hypertrophy to failure in the TAC CTR animals. 33 
HCN/I f remodelling in TAC ventricular myocytes
Previous data from rats and man indicated that the expression of I f is altered by pathological conditions like cardiomyopathy or cardiac hypertrophy, 12 -16 but data from mice are lacking. Patch clamp recordings with hyperpolarizing steps to 2140 mV elicited a timedependent, caesium-sensitive inward current ( Figure 2A and Supplementary material online, Figure S2 ). I f was present in 43% of TAC CTR myocytes (23 of 53 cells), but only in 14% of the myocytes from sham-operated mice (12 of 86 CTR cells, P , 0.001, Figure 2B ). I f was also clearly increased in TAC CTR cells as shown by the representative recordings in Figure 2A . The mean amplitude determined at 2140 mV was .2.5-fold higher in TAC CTR myocytes (472.4 + 58.3 pA; n ¼ 23) when compared with sham-operated animals (185.9 + 38.6 pA, n ¼ 12, P , 0.01). In addition, the current density was significantly increased from 6.6 + 1.5 to 11.5 + 1.4 nA/ mm 2 ( Figure 2C ). The altered expression of I f was present nearly to the same extent in both left and right ventricular myocytes (Supplementary material online, Table S1 ).
To get insights into the molecular mechanisms underlying I f remodelling, we examined the voltage dependence and activation kinetics of the current. I f is activated at more depolarized potentials in hypertrophied myocytes ( Figure 3A) . The potential of half-maximal activation (V 1/2 ) was significantly shifted by +7.4 mV from 2115.6 + 1.8 mV (CTR, n ¼ 7 cells) to 2108.2 + 1.4 mV (TAC CTR , n ¼ 15, P , 0.01). The speed of activation was examined by determining the activation constant (t) at 2140 mV ( Figure 3B ). The mean values for both groups were not significantly different (t CTR ¼ 1181 + 65 ms; n ¼ 7;
t TAC CTR ¼ 1003 + 122 ms; n ¼ 15). However, analysis of the distribution of current kinetics revealed that 90% of the I f -positive control cells exhibited activation constants slower than 1000 ms ( Figure 3C ). In contrast, the majority of TAC CTR myocytes displayed activation constants faster than 1000 ms; furthermore, 20% were faster than 500 ms. Such fast activation kinetics were seen exclusively in myocytes isolated from hypertrophied hearts.
Next, we determined the HCN isoform expression profile in ventricular samples. Under physiological conditions, HCN2 was by far the predominant isoform followed by HCN4 (Supplementary material online, Figure S3 ). Unexpectedly, expression of the major ventricular isoform HCN2 was not altered by cardiac hypertrophy ( Figure 3D ). The amount of HCN4 mRNA was also not increased under these conditions; in fact, the expression level was slightly diminished in the left ventricle (0.7-fold; P , 0.01). In contrast, the qRT-PCR experiments revealed a significant increase in HCN1 by a factor of 2.7 and 4.4 in left and right ventricular tissue samples, respectively (P , 0.01). A recent study demonstrated that RNA synthesis increases with cardiac hypertrophy reflecting increased myocyte size without an increase in myocyte number. 4 Therefore, we analysed isolated ventricular myocytes and normalized the expression levels to the cardiac cell size determined in each animal. Again, an increased expression of HCN1 was found in isolated left and right ventricular cells (P , 0.05 and P , 0.01, respectively), whereas the transcript levels of the other HCN isoforms were not changed significantly (Supplementary material online, Figure S4 ).
Creation of mice with working myocardial-specific HCN channel deficiency
To investigate the specific role of ventricular I f , we decided to create a conditional HCN KO. Floxed HCN2 and HCN4 mice were previously made in our lab. 21, 25 These two isoforms account together for over 90% of the ventricular HCN transcript and are widely accepted as the predominant ventricular isoforms. Therefore, we assumed that the combined deletion of HCN2 and HCN4 would largely eliminate I f in the ventricle. We crossed double-floxed HCN2/HCN4 animals with MCK-Cre transgenic mice. 23 Expression of the Cre transgene is driven by the muscle creatine kinase promoter leading to recombinase activity in cardiac muscle, particularly in the working myocardium ( Figure 4A-C) .
It should be noted that the MCK-Cre-activity in skeletal muscle is not relevant in our model, since HCN channels are not expressed in this tissue. 23, 34, 35 The resulting double-KOs had normal size and weight and were indistinguishable from control animals. The deletion of the two target genes was highly efficient as shown by a complete loss of HCN2 and HCN4 transcripts in isolated myocytes ( Figure 4C) . The MCK-Cre transgene activity was mainly restricted to the working myocardium. Specimen of SA node tissue displayed only a minor reduction in HCN4, the main SA HCN isoform ( Figure 4D) . Thus, the mutants should possess a functional intact pacemaking system enabling an analysis of the specific role of I f in ventricular myocytes.
Characterization of ventricular HCN double-KO animals
The conditional deletion of HCN2 and HCN4 resulted in a complete ventricular I f KO. Ventricular myocytes were incapable to generate a Role of ventricular I f in cardiac disease pacemaker current upon membrane hyperpolarization, regardless if myocytes were analysed before or after induction of cardiac hypertrophy ( Figure 5A) . In no case, hyperpolarization-activated currents could be detected (n ¼ 26 KO and 32 TAC KO cells, Figure 5B ). The low HCN1 transcript levels in the basal state as well as the enhanced HNC1 levels in response to cardiac hypertrophy were similar to the expression in CTR animals ( Figure 5C) . Hence, the expression of HCN1 was not changed by the combined deletion of HCN2 and HCN4.
Cardiac function and development of hypertrophy in the double KOs
The deletion of ventricular I f did not result in a change of the physiological (non-hypertrophic) heart function. ECG parameters (PR, QRS, and QT c interval, P duration) were normal and no arrhythmias were detected. In addition, the mean heart rates were not different between KOs (488 + 22 bpm, n ¼ 9) and controls (451 + 1 bpm, n ¼ 13). Long-term ECG recordings displayed a regular modulation of heart rates during night-day cycles (Supplementary material online, Figure S5 ). The development of hypertrophy was also unaffected since KO animals subjected to the TAC procedure showed the same degree of cardiac hypertrophy as controls (Supplementary material online, Figures S1 and S6 ).
Examination of pro-arrhythmogenic parameters in hypertrophic hearts
Since prolongation of the APD has been frequently observed in ventricular hypertrophy, we assessed the APD in isolated heart experiments. 2 -4,36 As expected, the time periods required for repolarization to a level of 50, 70, and 90% were significantly prolonged in hypertrophic control hearts ( Figure 6A , Supplementary material online, Figure S7) . Surprisingly, in hypertrophic KO hearts, the action potential prolongation was significantly attenuated when compared with TAC CTR . This attenuation of the hypertrophy-induced action potential prolongation was robust over a range of paced cycle lengths and repolarization levels (Supplementary material online, Figure S7) . Moreover, at a basal cycle length of 80 ms, the APDs of hypertrophic KO hearts were comparable to non-hypertrophic controls ( Figure 6A) , suggesting an involvement of the I f current in the hypertrophy-induced action potential prolongation.
To get an additional confirmation of this unexpected result, we further examined action potentials in isolated myocytes recorded in the perforated patch configuration ( Figure 6B ). The APDs were again significantly longer in the hypertrophic control (181 + 16 ms, n ¼ 20) than in KO left ventricular myocytes (130 + 7 ms; n ¼ 18), whereas no difference was observed between non-hypertrophic cells. Resting membrane potentials and action potential amplitudes were not different in all groups.
We examined the expression of various K + channels involved in the repolarization of the ventricular action potential and found no difference in the expression levels between KO and control hearts in the basal as well as the hypertrophic state (Supplementary material online, Figures S8 ). This indicates that the observed attenuation of the APD in the I f KOs is not caused by an altered K + -channel expression. To examine if the deletion of ventricular I f and the associated diminished APD prolongation leads to functional alterations, ECGs were obtained from anaesthetized animals before and after TAC. In response to ventricular hypertrophy, the QT c intervals were significantly prolonged as has been shown also by others 4 ( Figure 6B) . However, the prolongation of the QT c interval was significantly less pronounced in hypertrophic KOs than in hypertrophic controls ( Figure 6B ), suggesting that I f contributes to an altered ventricular repolarization in TAC mice. Additionally, ventricular arrhythmias were investigated directly in isolated hypertrophic hearts of control and KO animals. We found relatively few spontaneous ventricular arrhythmias in both groups (15%). Also arrhythmia induction with a single extra stimulus caused no differences between the groups. Both showed sporadic non-sustained arrhythmias [up to 50% of TAC CTR (n ¼ 14) and 25% of TAC KO hearts (n ¼ 13)] with no significant difference in arrhythmia inducibility. In a next step, hearts were perfused with the b-receptor agonist orciprenaline (1.6 mM) and arrhythmias induced by programmed stimulation were studied. There were numerically fewer hearts with induced arrhythmias in the KO (31%) than in the control group (60%); however, this difference did not reach statistical significance. Mean maximal ventricular arrhythmia length of the baseline protocol was 2.36 s and 2.35 s in TAC CTR and TAC KO , respectively (P ¼ n.s.). Mean maximal ventricular arrhythmia length increased strongly with exposure to b-adrenergic stimulation to 47 s in TAC CTR and 52 s in TAC KO (P ¼ n.s.). 
Discussion
A participation of I f in the arrhythmogenic mechanisms of cardiac hypertrophy and failure has been suggested, 14, 15, 17 but direct evidence supporting or excluding this hypothesis is lacking. We used a murine model of ventricular hypertrophy and conditional KO mice with a working myocardial cell-specific deletion of I f to investigate this issue. Mutant and control mice were studied before and after pressure-overload induced cardiac hypertrophy with regard to the development of hypertrophy, expression profile of HCN channels, characteristics of I f , and the susceptibility to ventricular arrhythmias. Our approach allowed the examination of the arrhythmogenic potential of the current without a functional alteration of the cardiac pacemaking system. This is an advantage over the use of I f blockers in whole animal studies which do not allow targeting of HCN channels selectively in working myocardial cells. 
Expression of HCN channels in the normal and hypertrophic heart
Our data show that HCN2 and HCN4 are the predominant HCN transcripts in ventricular cells under basal conditions. We did not detect a significant increase in the mRNA levels of these two genes following the induction of hypertrophy. These results are in contrast to previous studies in rats 13, 37 and humans 16, 38 which described an increase in HCN2 and/or HCN4 transcripts in diseased hearts. It should be noted that these reports only partially agree, one study did not detect HCN2 in human ventricle 38 another observed first a decrease followed by an increase in HCN2 and HCN4 in hypertrophied rat hearts. 37 Nevertheless, the reason for the difference between our results and the above studies is not clear. It may be related to species differences since we used mice, whereas all other reports to date analysed rat or human tissue. In addition, different experimental animal models for ventricular hypertrophy have been employed and the studies using human tissue are complicated by inherent variability (different pathologies and disease states, drug therapy). An unexpected finding was the strong and robust increase in HCN1 in hypertrophy. This was surprising because under basal conditions HCN1 is expressed at only low levels. However, cardiac remodelling results in the re-expression of fetal genes. Mouse embryonic ventricular myocytes show high transcript levels of HCN1 which strongly decrease with further cardiac development. 11 Hence, the increased HCN1 mRNA expression observed in our TAC animals is in agreement with a re-induction of a fetal gene program.
Alterations of I f in cardiac hypertrophy
The contribution of HCN1 to ventricular I f is not clear. The combined deletion of HCN2 and HCN4 results in a complete loss of ventricular I f . The total lack of I f also in hypertrophic myocytes seems somewhat surprising and questions the role of HCN1. HCN1 represents 9 and 30% of the total HCN message under basal and hypertrophic conditions, respectively. It should be noted that we could not detect HCN1 as well as the other HCN isoforms on the protein level; hence, it is not clear if the amount of transcript relates directly to the amount of functional protein. Nevertheless, HCN1 alone is insufficient for generating a detectable current.
It is most likely that the different channel isoforms directly interact with each other to build heterotetramers. Generally, these channel complexes possess unique biophysical and regulatory properties compared with homomers. Ventricular I f is probably dependent on the co-assembling of different HCN isoforms and HCN1 homomers are not able to generate a functional ventricular current. In other ion channels, co-assembling is even essential for the formation of a fully functional channel and proper channel expression is controlled by additional subunits. We can only speculate about the reasons, but our experiments clearly show that the presence of HCN1 alone results in no detectable ventricular I f .
However, these considerations do not rule out an influence of HCN1 to ventricular I f in general. In the presence of other HCN subunits, HCN1 may participate to ventricular I f . In particular, the changes in the biophysical properties upon hypertrophy could be at least partly explained by the observed alterations in HCN isoform expression. HCN1 is the isoform with the fastest kinetic and also with the most depolarized potential of half-maximal activation; 6 -9,39,40 hence, a more pronounced contribution by HCN1 to ventricular I f could contribute to such modifications. However, the alterations in ventricular I f could also be caused by posttranslational modifications of channel characteristics. HCN channels are known to be regulated by phosphorylation as well as low molecular factors (e.g. PIP 2 ) which may stimulate channel activity in the course of ventricular remodelling.
Reduced prolongation of the APD in hypertrophic KO hearts
As expected, the TAC procedure resulted in a cardiac hypertrophy with typical characteristics of ventricular remodelling such as an increase in the HBR and ventricular myocyte size. In addition, electrocardiological alterations such as prolonged action potentials and increased QT c intervals which are consistent findings in hypertrophy models and in failing human hearts 41 were also observed in TAC hearts. It is thought that these abnormalities provoke electrical instability and increase the development of life-threatening arrhythmias. 2, 4 Remarkably, our KO experiments show that these proarrhythmic factors are significantly attenuated in TAC hearts as a consequence of ventricular I f deletion. At the first sight, a contribution of I f to ventricular repolarization seems astonishing. Ventricular repolarization is determined by potassium outward currents which exceed depolarizing inward currents. A proper repolarization is warranted by the so-called repolarization reserve describing the spare repolarizing capacity of normal hearts. 41 The remodelling process in cardiac disease states may lead to a depletion of this repolarization capacity due to reduced outward currents and/or increased inward currents. Therefore, the increased I f in TAC hearts may operate against repolarizing currents which cause electrical imbalance and hence prolongation of APD. This assumption is based on the well-known slow deactivation kinetic of I f /HCN channels. 42 Because of the relatively fast ventricular cycle length, the channels deactivate incompletely; therefore, HCN channel activity may manifest as a 'steady-state inward current' 42 -44 which contributes to the action potential depolarization as well as repolarization phase. Our results implicate that deletion/inhibition of ventricular I f improves repolarization reserve and helps maintain electrical stability in cardiac disease states. Hence, targeting ventricular HCN channels may be an attractive approach for reducing the arrhythmic potential in cardiac hypertrophy and failure. Importantly, the complete loss of ventricular I f in the healthy heart did not lead to detectable functional consequences, indicating that the role of the current under these conditions is probably minor. However, the current is strongly increased during cardiac hypertrophy and contributes significantly to prolongation of the repolarization phase. Therefore, it appears that drugs which block ventricular HCN channels act on disease-associated ion channels. Such a positive influence on pro-arrhythmogenic factors may be at least partly responsible for the beneficial effect of the I f -blocker ivabradine on cardiovascular mortality in heart failure. 19 
Investigation of arrhythmias in the isolated heart preparation
The isolated heart experiments showed no difference in the occurrence of spontaneous and single stimulus-induced ventricular arrhythmias. After perfusion with orciprenaline, there were numerically fewer hearts with induced arrhythmias in the KO than in the control group; however, this difference did not reach statistical significance. The Langendorff setup and the electrophysiological protocols applied have been extensively and successfully used to detect proarrhythmia. 27 -32 In this case, the setting may not have been optimal as proarrhythmia was neither ruled out nor clearly proven with significance, but the blinding of all procedures and the multiple groups used makes protocol changes within the ongoing study difficult. Another study with larger animal numbers and adapted electrophysiology protocols may be indicated to investigate proarrhythmia in this cohort in the future.
Supplementary material
Supplementary material is available at Cardiovascular Research online. , non-hypertrophic knockouts (KO, black column; n ¼ 9), hypertrophic controls (TAC CTR , light grey column; n ¼ 20), and hypertrophic knockouts (TAC KO , dark grey column; n ¼ 18). (C) QT c interval durations in non-hypertrophic controls (CTR, white column; n ¼ 5), non-hypertrophic knockouts (KO, black column; n ¼ 5), hypertrophic controls (TAC CTR , light grey column; n ¼ 8), and hypertrophic KOs (TAC KO , dark grey column; n ¼ 8). QT c values are significantly longer in hypertrophic hearts (CTR vs. TAC CTR , P , 0.001; KO vs. TAC KO , P , 0.01). n.s. ¼ P . 0.05, **P , 0.01, ***P , 0.001.
Role of ventricular I f in cardiac disease
